Cita APA

Frey, R., Mück, W., Kirschbaum, N., Krätzschmar, J., Weimann, G., & Wensing, G. (2009). Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521). BioMed Central.

Citación estilo Chicago

Frey, Reiner, Wolfgang Mück, Nina Kirschbaum, Jörn Krätzschmar, Gerrit Weimann, y Georg Wensing. Warfarin Pharmacodynamics and Pharmacokinetics Are Not Affected By the Soluble Guanylate Cyclase Stimulator Riociguat (BAY 63-2521). BioMed Central, 2009.

Cita MLA

Frey, Reiner, et al. Warfarin Pharmacodynamics and Pharmacokinetics Are Not Affected By the Soluble Guanylate Cyclase Stimulator Riociguat (BAY 63-2521). BioMed Central, 2009.